Clinical Trial Update: Role of Neutrophil Activation in Anaphylaxis to Neuro-Muscular Blocking Agents

View source ↗

Summary

A completed clinical trial investigates the role of neutrophil activation in anaphylaxis caused by neuromuscular blocking agents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis

Drugs mentioned

• Neuromuscular blocking agents

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Anaphylactic Shock to Neuro-Muscular Blocking Agents (NMBA) | Status: COMPLETED